GPT and metabolic dysfunction-associated steatotic liver disease: Administration of Lactobacillus sakei MJM60958 reduced body weight and liver weight and attenuated the NAFLD-related biomarkers, such as ALT, AST, TG, BUN, and UA, and reduced hepatic damage in the NAFLD mice model.